Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study
- 9 November 2004
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 13 (1), 57-65
- https://doi.org/10.1007/s00520-004-0731-1
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The Efficacy and Safety of Oral Immediate-Release Oxymorphone for Postsurgical PainAnesthesia & Analgesia, 2004
- Single Nucleotide Polymorphisms in the Human μ Opioid Receptor Gene Alter Basal G Protein Coupling and Calmodulin BindingJournal of Biological Chemistry, 2001
- Sequence variability and candidate gene analysis in complex disease: association of micro opioid receptor gene variation with substance dependenceHuman Molecular Genetics, 2000
- Long-Term Patterns of Morphine Dosage and Pain Intensity Among Cancer PatientsThe Hospice Journal, 1999
- The intrinsic antinociceptive effects of oxycodone appear to be κ -opioid receptor mediatedPain, 1997
- Pharmacology and mechanisms of opioid analgesic activityActa Anaesthesiologica Scandinavica, 1997
- Practice Guidelines for Cancer Pain ManagementAnesthesiology, 1996
- Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: Short- and long-term experiences in a prospective study of 39 patientsJournal of Pain and Symptom Management, 1996
- Randomized evaluation of controlled-release codeine and placebo in chronic cancer painJournal of Pain and Symptom Management, 1995
- Comparisons of the Analgesic Effects of Oral and Intramuscular Oxymorphone and of Intramuscular Oxymorphone and Morphine in Patients with CancerThe Journal of Clinical Pharmacology, 1977